AGM/EGMAug 6, 2026, 05:03 PM
Anterix Stockholders Approve 1M Share Increase for 2023 Stock Plan
AI Summary
Anterix Inc. stockholders approved Amendment No. 2 to the 2023 Stock Plan at the 2026 Annual Meeting, increasing the number of shares available for issuance by 1.0 million. Additionally, seven directors were elected, and advisory votes on executive compensation and its one-year frequency were approved. Deloitte & Touche LLP was also ratified as the independent registered public accounting firm for the fiscal year ending March 31, 2027.
Key Highlights
- Stockholders approved Amendment No. 2 to the 2023 Stock Plan.
- The amendment increases shares available for issuance by 1.0 million.
- Seven directors were elected to serve until the 2027 Annual Meeting.
- Advisory vote on executive compensation was approved with 14,641,617 votes FOR.
- Advisory vote for 1-year frequency for future executive compensation votes was approved with 14,425,357 votes FOR.
- Deloitte & Touche LLP was ratified as the independent auditor with 17,331,529 votes FOR.
- The Annual Meeting had a quorum of 17,347,869 shares, representing 90.06% of eligible shares.
Price Impact
More from ATEX